Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-014-3080-x
Published Online: 2014-08-09
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Arthur, L. M.
Turnbull, A. K.
Renshaw, L.
Keys, J.
Thomas, J. S.
Wilson, T. R.
Lackner, M. R.
Sims, A. H.
Dixon, J. M.
Text and Data Mining valid from 2014-08-01